# PREFerred Neurostimulation MODdalities - PREFMOD Study

> **NCT04582721** · NA · UNKNOWN · sponsor: **Ospedale Regionale di Lugano** · enrollment: 18 (estimated)

## Conditions studied

- Chronic Low-back Pain

## Interventions

- **OTHER:** Implantable Neurostimulator System (Spectra WaveWriter™ Spinal Cord Stimulator System), (Boston Scientific Neuromodulation Corporation, Valencia, California (CA), USA)

## Key facts

- **NCT ID:** NCT04582721
- **Lead sponsor:** Ospedale Regionale di Lugano
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2022-04-09
- **Final completion:** 2023-04-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2021-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04582721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04582721, "PREFerred Neurostimulation MODdalities - PREFMOD Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04582721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*